Bepreve (Bepotastine Besilate Ophthalmic Solution 1.5%) Drug Information: Medication Guide and Patient Information

Pill Identifier Search

May 25, 2012

Bepreve

Allergy »

Allergy facts

Allergy involves an exaggerated response of the immune system.
The immune system is the body's organized defense mechanism against foreign invaders, particularly infections.
Allergens are substances that are foreign to the body and can cause an allergic reaction.
IgE is the allergy antibody.
Allergies can develop at any age.
Your risk of developing allergies is related to your parents' allergy history.

Introduction

In this review you will learn how allergy relates to the immune system. You will begin understanding how and why certain people become allergic. The most common allergic diseases are discussed briefly in this article.

What does an allergy mean?

An allergy refers to an exaggerated reaction by our immune system in response to bodily contact with certain foreign substances. It is exaggerated because these f...

Read the Allergy article »

« Previous
1
2
3
4
5
6
7
8
9
10
Next »

Bepreve User Reviews >>

Bepreve

10 Common Allergy Triggers Slideshow Pictures

Take the Quiz on Allergies

Nasal Allergy Relief Slideshow Pictures

font size

PATIENT INFORMATION

Topical Ophthalmic Use Only

For topical ophthalmic administration only.

Sterility of Dropper Tip

Patients should be advised to not touch dropper tip to any surface, as this may contaminate the contents.

Concomitant Use of Contact Lenses

Patients should be advised not to wear a contact lens if their eye is red. Patients should be advised that BEPREVE™ (bepotastine besilate ophthalmic solution 1.5%) should not be used to treat contact lens-related irritation.

Patients should also be advised to remove contact lenses prior to instillation of BEPREVE™ (bepotastine besilate ophthalmic solution 1.5%) . The preservative in BEPREVE™ (bepotastine besilate ophthalmic solution 1.5%) , benzalkonium chloride, may be absorbed by soft contact lenses. Lenses may be reinserted after 10 minutes following administration of BEPREVE™ (bepotastine besilate ophthalmic solution 1.5%) .

Last reviewed on RxList: 9/17/2009
This monograph has been modified to include the generic and brand name in many instances.